Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting

作者: Peace Mabeta

DOI: 10.3390/IJMS19041192

关键词:

摘要: Genetic lesions in proto-oncogenes result the perturbation of angiogenesis, formation neovessels from a pre-existing microvasculature. Similarly, subversion tumor suppressor genes promotes vascularization. Excessive neovessel is associated with various neoplasms such as infantile hemangiomas (IH). Hemangiomas are most common tumors pediatric patients and at present have no definitive treatment. The pathogenesis IH not well understood; however, both vasculogenesis angiogenesis hemangioma genesis. A number factors that modulate been shown to be dysregulated IH. Several oncogenes suppressors linked promotion also altered hemangioma. In this review, roles during neovascularization genesis explored. addition, potential for targeting these therapy discussed.

参考文章(84)
M. Wassef, M. Berard, N. Peyri, N. Ortega, J. Plouet, L. Drouet, S. Sordello, N. Bertrand, O. Enjolras, Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas. American Journal of Pathology. ,vol. 150, pp. 1315- 1326 ,(1997)
Peter J. Polverini, Robert M. Strieter, David J. Mooney, Jacques E. Nör, Joan Christensen, Martin Peters, Jianguo Liu, Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Research. ,vol. 61, pp. 2183- 2188 ,(2001)
Animesh Pardanani, Claire Harrison, Jorge E. Cortes, Francisco Cervantes, Ruben A. Mesa, Donald Milligan, Tamás Masszi, Elena Mishchenko, Eric Jourdan, Alessandro M. Vannucchi, Mark W. Drummond, Mindaugas Jurgutis, Kazimierz Kuliczkowski, Emanuil Gheorghita, Francesco Passamonti, Frank Neumann, Abhay Patki, Guozhi Gao, Ayalew Tefferi, Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial. JAMA Oncology. ,vol. 1, pp. 643- 651 ,(2015) , 10.1001/JAMAONCOL.2015.1590
Annamaria Biroccio, Antonio Candiloro, Marcella Mottolese, Orazio Sapora, Adriana Albini, Gabriella Zupi, Donatella Del Bufalo, Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line The FASEB Journal. ,vol. 14, pp. 652- 660 ,(2000) , 10.1096/FASEBJ.14.5.652
Wei-Kang Pan, Peng Li, Zheng-Tuan Guo, Qiang Huang, Ya Gao, Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway. Pediatric Blood & Cancer. ,vol. 62, pp. 1414- 1420 ,(2015) , 10.1002/PBC.25453
Samer Kaylani, Amy J. Theos, Joseph G. Pressey, Treatment of Infantile Hemangiomas with Sirolimus in a Patient with PHACE Syndrome Pediatric Dermatology. ,vol. 30, pp. e194- e197 ,(2013) , 10.1111/PDE.12023
Subbiah Pugazhenthi, Albina Nesterova, Carol Sable, Kim A. Heidenreich, Linda M. Boxer, Lynn E. Heasley, Jane E.-B. Reusch, Akt/Protein Kinase B Up-regulates Bcl-2 Expression through cAMP-response Element-binding Protein Journal of Biological Chemistry. ,vol. 275, pp. 10761- 10766 ,(2000) , 10.1074/JBC.275.15.10761
Candelaria Gomez-Manzano, Juan Fueyo, Hong Jiang, Tricia L. Glass, Ho-Young Lee, Min Hu, Juinn-Lin Liu, Sushma L. Jasti, Ta-Jen Liu, Charles A. Conrad, W. K. Alfred Yung, Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis Annals of Neurology. ,vol. 53, pp. 109- 117 ,(2003) , 10.1002/ANA.10396
Alessia Bottos, Alberto Bardelli, Oncogenes and angiogenesis: a way to personalize anti-angiogenic therapy? Cellular and Molecular Life Sciences. ,vol. 70, pp. 4131- 4140 ,(2013) , 10.1007/S00018-013-1331-3
Peace Mabeta, Michael S. Pepper, Hemangiomas - current therapeutic strategies. The International Journal of Developmental Biology. ,vol. 55, pp. 431- 437 ,(2011) , 10.1387/IJDB.103221PM